CSL managed to shrug off the Ozempic effect and this week’s setback linked to a disappointing phase three trial thanks to its CSL Behring blood products business.
The IML Concentrated Australian Share Fund (Quoted Managed Fund) is now available on the ASX as an active ETF, catering to financial advisers and retail investors.